ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.01 and traded as low as $0.0050. ProtoKinetix shares last traded at $0.0050, with a volume of 500 shares.
ProtoKinetix Price Performance
The firm has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Recommended Stories
- Five stocks we like better than ProtoKinetix
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
